We are monitoring the impact of COVID-19 on North America Mycoplasma Testing Market Get in touch with us for detailed analysis Know More
Share on

North America Mycoplasma Testing Market Research Report - Segmented By Product, Technique, Application, End-User & Country (US, Canada & Rest of North America) - Industry Analysis, Size, Share, Growth, Trends, & Forecast To 2027

Published: January, 2022
ID: 3520
Pages: 136

North America Mycoplasma Testing Market Size & Growth (2022 to 2027):

According to the report, the Size of the North America Mycoplasma Testing Market is valued at USD 210.74 Million in 2022 and is projected to be growing at a CAGR of 11.5%, to reach USD 363.17 Million by 2027 during the forecast period 2022 to 2027.

DRIVERS

Factors such as high R&D expenditure by bio-pharmaceutical companies, increase in government initiatives and research, high degree technological advancements, along with demand for rapid, accurate & affordable tests and increase in contamination of cell cultures further stimulate the mycoplasma market.

The other factor includes the efficiency of polymerase chain reaction tests that is increasing application in clinical diagnostics, the increasing demand for personalized and precision medicine, and technological advancements and applications in drug development.

Mycoplasma infection is complex to see under a microscope and requires specific tests to be detected. Infection can have an acute impact on experimental work depending on the species present. Mycoplasma organisms can affect cell growth, teratogenic, metabolism, and response to chemotherapy. Increased research activity by pharmaceutical and biotechnology companies, increased government support and funding for research activities, and growing contamination of cell cultures around the world are the few factors responsible for the high CAGR market for the upcoming forecast period.

RESTRAINTS

However, there are some strict government regulations in several developed and emerging countries and a high degree of consolidation for new entrants, which are among the major obstacles to the growth of the mycoplasma testing market.

Factors such as the lack of trained professionals, physicians and the lack of standards and protocols are limiting the growth of the market. For optimum effectiveness, the mycoplasma testing procedure should be performed by trained professionals with sufficient knowledge of the nuances of this area. Handling the instruments used in mycoplasma testing also requires experience and professionals. Hence, the lack of a sufficiently skilled workforce is hampering the growth of the Mycoplasma Testing market.

OPPORTUNITIES

Developments in techniques such as Polymerase Chain Reaction (PCR), Enzyme Immunoassay (ELISA), Enzyme Reaction and DNA Staining during pandemic, has increased the growth rate. The polymerase chain reaction (PCR) very popular and is expected have the highest CAGR for the forecast period. Factors that can be attributed to the popularity of PCR are due to the precision, speed and flexibility that this technique offers in life science research.

CHALLENGES

Mycoplasma organisms can affect various cellular response and can give false results as they are techniques sensitive. Hence care should be taken to check for the presence of Mycoplasma in cell banks and biotechnology labs, otherwise it can further spoil cell culture based research, which is challenging the growth rate of the market.

This research report on the North America Mycoplasma Testing Market has been segmented and sub-segmented into the following categories

By Product:

  • Kits & Reagents
  • Instruments
  • Services

By Technique:

  • PCR
  • ELSA
  • Direct Assays
  • Indirect Assays
  • Microbial Culture Techniques
  • Enzymatic Methods
  • DNA Staining

By Application:

  • Cell Line Testing
  • Virus Testing
  • End-Of-Production Cell Testing
  • Others

By End-User:

  • Pharmaceutical Companies
  • Contract Research Organizations
  • Academic Research Institutes
  • Cell Banks

By Country:

  • US
  • Canada
  • Rest of North America.

REGIONAL ANALYSIS

The North America Mycoplasma Testing market is expected to exhibit a healthy CAGR during the forecast period. The U.S mycoplasma testing market and is expected to maintain the same position for a few more years. This region is expected to increase its market share in the future, due to its well-established healthcare industry and the increasing prevalence of chronic diseases in the region. Other growth factors in this region are the presence of global biotechnology companies and pharmaceutical players and increased investment in R&D activities in the region.

Canada Mycoplasma Testing Market is also expected to have a healthy growth rate, this is due to the increase in healthcare costs associated with the rapid uptake of point-of-care testing, expanding healthcare spending and increased investment by the government.

Promising Companies leading the North America Mycoplasma Testing Market Profiled in the Report are PromoCell GmbH, Thermo Fisher Scientific Inc., Minerva Biolabs GmbH, Lonza Group Ltd., Charles River Laboratories International, Inc., Gibraltar Laboratories, Sartorius AG, Merck KGaA, Roche Diagnostics, SGS S.A., American Type Culture Collection, InvivoGen, WuXi AppTec.,

1.Introduction        

                1.1 Market Definition                    

                1.2 Study Deliverables                  

                1.3 Base Currency, Base Year and Forecast Periods

                1.4 General Study Assumptions                

2. Research Methodology                 

                2.1 Introduction     

                2.2 Research Phases                      

      2.2.1 Secondary Research           

      2.2.2 Primary Research 

      2.2.3 Econometric Modelling      

      2.2.4 Expert Validation  

                2.3 Analysis Design                         

                2.4 Study Timeline

3. Overview             

                3.1 Executive Summary                

                3.2 Key Inferences                         

                3.3 Epidemiology    

4. Drivers, Restraints, Opportunities, and Challenges Analysis (DROC)          

                4.1 Market Drivers

                4.2 Market Restraints                    

                4.3 Key Challenges                         

                4.4 Current Opportunities in the Market    

5. Market Segmentation                    

                5.1 Product                        

      5.1.1 Introduction           

      5.1.2 Kits & Reagent       

      5.1.3 Instruments           

      5.1.4 Services    

      5.1.5  Y-o-Y Growth Analysis, By Product              

      5.1.6  Market Attractiveness Analysis, By Product            

      5.1.7  Market Share Analysis, By  Product             

                5.2 Technique                   

      5.2.1 Introduction           

      5.2.2 PCR            

      5.2.3 ELSA           

      5.2.4 Direct Assays          

      5.2.5 Indirect Assays      

      5.2.6 Microbial culture techniques           

      5.2.7 Enzymatic Methods            

      5.2.8 DNA Staining          

      5.2.9 Y-o-Y Growth Analysis, By Technique          

      5.2.10 Market Attractiveness Analysis, By Technique      

      5.2.11 Market Share Analysis, By Technique       

                5.3 Application                 

      5.3.1 Introduction           

      5.3.2 Cell Line Testing    

      5.3.3 Virus Testing          

      5.3.4 End-Of-Production Cell Testing      

      5.3.5 Other Applications               

      5.3.6 Y-o-Y Growth Analysis, By Application         

      5.3.7  Market Attractiveness Analysis, By Application      

      5.3.8  Market Share Analysis, By Application       

                5.4 End-User                      

      5.4.1 Introduction           

      5.4.2 Pharmaceutical Companies              

      5.4.3 Contract Research Organizations   

      5.4.4 Academic Research Institutes         

      5.4.5 Cell Banks

      5.4.6 Y-o-Y Growth Analysis, By End User             

      5.4.7 Market Attractiveness Analysis, By End User           

      5.4.8 Market Share Analysis, By End User             

6. Geographical Analysis                    

                6.1 Introduction     

      6.1.1 Regional Trends    

      6.1.2 Impact Analysis     

      6.1.3 Y-o-Y Growth Analysis        

                      6.1.3.1 By Geographical Area

                      6.1.3.2 By Product

                      6.1.3.3 By Technique

                      6.1.3.4 By Application

                      6.1.3.5 By End User

      6.1.4  Market Attractiveness Analysis     

                      6.1.4.1 By Geographical Area

                      6.1.4.2 By Product

                      6.1.4.3 By Technique

                      6.1.4.4 By Application

                      6.1.4.5 By End User

      6.1.5  Market Share Analysis      

                      6.1.5.1 By Geographical Area

                      6.1.5.2 By Product

                      6.1.5.3 By Technique

                      6.1.5.4 By Application

                      6.1.5.5 By End User

                6.2 United States  

                6.3 Canada                         

7.Strategic Analysis              

                7.1 PESTLE analysis                         

      7.1.1 Political     

      7.1.2 Economic 

      7.1.3 Social         

      7.1.4 Technological         

      7.1.5 Legal          

      7.1.6 Environmental       

                7.2 Porter’s Five analysis    

      7.2.1 Bargaining Power of Suppliers        

      7.2.2 Bargaining Power of Consumers    

      7.2.3 Threat of New Entrants     

      7.2.4 Threat of Substitute Products and Services              

      7.2.5 Competitive Rivalry within the Industry     

8.Market Leaders' Analysis               

                8.1 Thermo Fisher Scientific Inc.     

      8.1.1 Overview 

      8.1.2 Product Analysis   

      8.1.3 Financial analysis  

      8.1.4 Recent Developments       

      8.1.5 SWOT analysis       

      8.1.6 Analyst View          

                8.2 Minerva Biolabs GmbH

                8.3 Charles River Laboratories International                        

                8.4 Gibraltar Laboratories  

                8.5 Sartorius AG     

                8.6 Lonza Group Ltd.                      

                8.7 Merck KGaA     

                8.8 Roche Diagnostics                    

                8.9 SGS S.A.                       

                8.10 American Type Culture Collection                  

                8.11 InvivoGen                 

                8.12 PromoCell GmbH                   

                8.13 Biological Industries Israel Beit Haemek Ltd.    

                8.14 WuXi AppTec 

9.Competitive Landscape                  

                9.1 Market share analysis  

                9.2 Merger and Acquisition Analysis                       

                9.3 Agreements, Collaborations, and Joint Ventures                         

                9.4 New Product Launches                         

10.Market Outlook and Investment Opportunities                

Appendix                 

                a) List of Tables                

                b) List of Figures    

  1. North America Mycoplasma Testing Market By Product, From 2022 - 2027 ( USD Billion )
  2. North America Kits & Reagent Market By Region, From 2022 - 2027 ( USD Billion )
  3. North America Instruments      Market By Region, From 2022 - 2027 ( USD Billion )
  4. North America Services  Market By Region, From 2022 - 2027 ( USD Billion )
  5. North America Mycoplasma Testing Market By Technique, From 2022 - 2027 ( USD Billion )
  6. North America PCR  Market By Region, From 2022 - 2027 ( USD Billion )
  7. North America ELSA   Market By Region, From 2022 - 2027 ( USD Billion )
  8. North America Direct Assays Market By Region, From 2022 - 2027 ( USD Billion )
  9. North America Indirect Assays Market By Region, From 2022 - 2027 ( USD Billion )
  10. North America Microbial culture techniques Market By Region, From 2022 - 2027 ( USD Billion )
  11. North America Enzymatic Methods Market By Region, From 2022 - 2027 ( USD Billion )
  12. North America DNA Staining Market By Region, From 2022 - 2027 ( USD Billion )
  13. North America Mycoplasma Testing Market By Application, From 2022 - 2027 ( USD Billion )
  14. North America Cell Line Testing Market By Region, From 2022 - 2027 ( USD Billion )
  15. North America Virus Testing Market By Region, From 2022 - 2027 ( USD Billion )
  16. North America Cell Testing Market By Region, From 2022 - 2027 ( USD Billion )
  17. North America Mycoplasma Testing Market By  End User, From 2022 - 2027 ( USD Billion )
  18. North America Pharmaceutical Companies Market By Region, From 2022 - 2027 ( USD Billion )
  19. North America Contract Research Organizations  Market By Region, From 2022 - 2027 ( USD Billion )
  20. North America Academic Research Institutes Market By Region, From 2022 - 2027 ( USD Billion )
  21. North America Cell Banks Market By Region, From 2022 - 2027 ( USD Billion )
  22. United States Mycoplasma Testing Market By Product, From 2022 - 2027 ( USD Billion )
  23. United States Mycoplasma Testing Market By Technique, From 2022 - 2027 ( USD Billion )
  24. United States Mycoplasma Testing Market By Application, From 2022 - 2027 ( USD Billion )
  25. United States Mycoplasma Testing Market By  End User, From 2022 - 2027 ( USD Billion )
  26. Canada Mycoplasma Testing Market By Product, From 2022 - 2027 ( USD Billion )
  27. Canada Mycoplasma Testing Market By Technique, From 2022 - 2027 ( USD Billion )
  28. Canada Mycoplasma Testing Market By Application, From 2022 - 2027 ( USD Billion )
  29. Canada Mycoplasma Testing Market By  End User, From 2022 - 2027 ( USD Billion )
  30. North America Mycoplasma Testing  Market By Kits & Reagent, From 2022 - 2027 ( USD Million )
  31. North America PCR Assays Market By Region, From 2022 - 2027 ( USD Million )
  32. North America Nucleic Acid Detection Kits Market By Region, From 2022 - 2027 ( USD Million )
  33. North America Elimination Kits & Reagents Market By Region, From 2022 - 2027 ( USD Million )
  34. North America Stains Market By Region, From 2022 - 2027 ( USD Million )
  35. North America Standards & Controls Market By Region, From 2022 - 2027 ( USD Million )
  36. North America Other Kits & Reagents Market By Region, From 2022 - 2027 ( USD Million )
  37. United States Mycoplasma Testing  Market By Kits & Reagent, From 2022 - 2027 ( USD Million )
  38. Canada Mycoplasma Testing  Market By Kits & Reagent, From 2022 - 2027 ( USD Million )

Please wait. . . . Your request is being processed

Related Reports

PURCHASE OPTIONS

excel
$

3335


pdf excel
$

3680


pdf excel powerbi
$

5520


excel
$

2000

What You Get :

  • PDF Report Format.
  • Can be accessible by 1 single user.
  • 6 Months of Free Analyst Support.
  • PDF and Excel Datasheet Formats.
  • Can be accessible upto 2 to 5 users.
  • 1 Year of Free Analyst Support.
  • PDF, Excel and Power BI Dashboard.
  • Can be accessible by unlimited users.
  • 1 Year of Free Analyst Support.
  • Excel Datasheet Format.
  • Customized access as per user request.
  • Upgradable to other licenses.
customer-support
ASK FOR CUSTOMIZATION

Talk to our analyst and get customised report done according to your research needs

tag
INQUIRE FOR DISCOUNT

Check if you can avail any discount. Submit your details and our team will get back to you.

cloud-download
DOWNLOAD FREE SAMPLE

Request to avail a free sample report that reflects this market and its growth.

Access the study in MULTIPLE FORMATS
Purchase options starting from $ 3335

Didn’t find what you’re looking for?
TALK TO OUR TEAM

Find it too expensive?
NO WORRIES!

Click for Request Sample